2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò : 2024-06-28
±³À°ÀÏÀÚ : 2024-06-28
±³À°Àå¼Ò : ¾Ú¹ö¼´õ ¼¿ï Ç®¸¸ È£ÅÚ ±×·£µåº¼·ë 2Ãþ
±³À°ÁÖÁ¦ : 2024 Á¦3ȸ ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ Ä¡·á½ÉÆ÷Áö¿ò
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ
´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674
À̸ÞÀÏ : gschoi@humming.co.kr
±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ȸ¿ø 2¸¸¿øºñȸ¿ø 30¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06¿ù 28ÀÏ 17:10~17:40 (±³À°°¿¬)Current and emerging topicals and complementary therapies ±èÁöÈñ(¿¬¼¼´ëÇб³ ¿ëÀμ¼ºê¶õ½º ÇǺΰú)
±³À°½Ã°£ 06¿ù 28ÀÏ 17:40~18:10 (±³À°°¿¬)Practical pearls of systemic immunomodulators ¹Ú±Í¿µ(Á߾Ӵ뺴¿ø ÇǺΰú)
Åä·Ð 06¿ù 28ÀÏ 18:10~18:20 ÁúÀÇÀÀ´ä ()
½Ä»ç 06¿ù 28ÀÏ 18:20~19:00 ½Ä»ç ()
±³À°½Ã°£ 06¿ù 28ÀÏ 19:00~19:30 (±³À°°¿¬)Optimal use of biologics ¹Úâ¿í(¿¬¼¼´ëÇб³ ½ÅÃ̼¼ºê¶õ½º ÇǺΰú)
±³À°½Ã°£ 06¿ù 28ÀÏ 19:30~20:00 (±³À°°¿¬)Optimal use of JAK inhibitors Àå¿ëÇö(°æºÏ´ëº´¿ø ÇǺΰú)
Åä·Ð 06¿ù 28ÀÏ 20:00~20:10 ÁúÀÇÀÀ´ä ()
ÈÞ½Ä 06¿ù 28ÀÏ 20:10~20:20 ÈÞ½Ä ()
±³À°½Ã°£ 06¿ù 28ÀÏ 20:20~20:50 (±³À°°¿¬)Targeted therapies for type 2 inflammatory diseases ÀÌÁöÇö(¼¿ï¼º¸ðº´¿ø ÇǺΰú)
±³À°½Ã°£ 06¿ù 28ÀÏ 20:50~21:20 (±³À°°¿¬)Disease modification in atopic disorders ÀüÁöÇö(°í·Á´ëÇб³ ±¸·Îº´¿ø ÇǺΰú)
Åä·Ð 06¿ù 28ÀÏ 21:20~21:30 ÁúÀÇÀÀ´ä ()